Biocracked
Approach: the human outcome. Palette: natural.

Extreme close-up of a woman's eye and the delicate skin around it, shot from a slight three-quarter angle with a 100mm macro lens and a shallow depth of field. Her skin is a mature 50s complexion with fine crow's feet that are sharp and tactile, with visible pores and soft vellus hairs. Her gaze is relaxed and not at the camera, and the face is cropped so identity isn't the focus. Soft, directional window daylight rakes across the skin from the left to bring out the wrinkle texture, with gentle warm skin tones and a blurred leafy green background outdoors. A single glass of water with a faint dissolving powder swirl sits out of focus in the foreground, with a tiny electric green leaf highlight at the edge. The mood is calm, honest and quietly scientific.
Peptides

Gram 2.5 na Peptide Collagen Ya Rage Tabon Idanu da Kashi 20% Cikin Makonni 8

Nova Chen · · 6 min read

Gram 2.5 na Peptide Collagen Ya Rage Tabon Idanu da Kashi 20% Cikin Makonni 8

Taƙaitaccen Bayani: Collagen ɗaya daga manyan abubuwan da ake nema a fannin kwalliya da tsawon rai, amma mafi yawan samfuran suna da takardun placebo ne kawai. A wani gwaji da mata 114 masu shekaru 45‑65 suka halarta, gram 2.5 na takamaiman peptide mai aiki Verisol ya rage ƙyallin tabon idanu da kashi 20 % idan aka kwatanta da placebo bayan makonni 8. Biopsies sun nuna ƙaruwa a procollagen I da kashi 65 % da elastin da kashi 18 %, yayin da ƙaruwa a fibrillin (6 %) ba ta da muhimmanci. Tasirin ya ci gaba da bayyana har makonni 4 bayan shan ƙarshe, amma sakamakon ya shafi peptide ɗaya ne kawai a ƙungiyar mata, ba kowanne foda na collagen ba.

Abun Ciki

Collagen powders suna ko'ina, amma mafi yawansu suna ɗauke da alkawura marasa tabbas da kuma ƙananan takardun kimiyya. Wannan rafin gwaji double‑blind, placebo‑controlled ne. A cikinsa, gram 2.5 a rana na takamaiman peptide collagen mai aiki ya rage ƙyallin tabon idanu da kashi 20 % idan aka kwatanta da placebo bayan makonni 8. Biopsies suma sun nuna ƙaruwar procollagen I a fata. Matsalar ita ce, sakamakon ya shafi peptide ɗaya mai alama Verisol, wadda aka gwada a ƙungiyar mata kawai. Ba ya nufin kowanne foda na collagen da ke kan tebur ba.

Waɗannan rubutun na bayyana abin da binciken ya yi, abin da ya gano, da iyakokin sakamakonsa.

Abin da Binciken Ya Yi

Takardar da aka rubuta Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis ta ƙunshi Proksch E, Schunck M, Zague V, Segger D, Degwert J da Oesser S, kuma an wallafa ta a Skin Pharmacology and Physiology a shekarar 2014 (27(3):113‑119). Cikakken bayanin takardar yana a kan PubMed.

Tsarin Binciken

  • Mata 114 masu shekaru 45‑65, an raba su daidai (57 a kowanne rukuni)
  • Gram 2.5 na peptide collagen mai aiki Verisol, ko placebo, sau ɗaya a rana tsawon makonni 8
  • Double‑blind da placebo‑controlled
  • An auna ƙyallin tabo a matakin farko, makonni 4 da makonni 8, sannan an ƙara makonni 4 na lokaci na dawowa bayan ƙarshe ƙarin magani
  • Ƙungiyar ƙanana ta sami biopsy na suction blister a matakin farko da makonni 8. An auna procollagen I, elastin da fibrillin a fata.

Auna ƙyallin tabo da biopsies ne suka bambanta wannan gwaji da yawancin ƙarin kayan abinci da suka dogara da tambayoyin “fata na ji daɗi”.

Peptide Collagen Mai Aiki vs. Collagen Na Kowa

Collagen wani protein ne na gina jiki. “Collagen supplements” na iya nufin abubuwa dabam‑dabam, daga gelatin zuwa powders da ba a fayyace ba. Peptide collagen mai aiki (BCP) shi ne takamaiman tsari na ƙwayoyin peptide da aka tantance. Manufar takardar Verisol ita ce masu binciken sun gwada peptide ɗaya takamaimai, ba collagen gaba ɗaya ba.

Masu rubutu sun bayyana hakan a fili: “takamaiman peptide collagen mai aiki (Verisol®).” Idan ka sayi wani samfurin collagen daban, wannan gwaji ba ya ba da wani tabbaci ko zai yi aiki ba. Wataƙila zai yi, amma ba a tabbatar da hakan a wannan binciken ba.

Muhimman Sakamako, Tare da Lissafi

Ƙyallin Tabon Idanu

  • Ƙyallin tabo ya ragu sosai (p < 0.05) idan aka kwatanta da placebo a makonni 4 da 8. Rage a makonni 8 ya kai kashi 20 %.
  • Tasiri mai ɗorewa har ma ya kasance mai muhimmanci (p < 0.05) makonni 4 bayan ƙarshe ƙarin magani.

Matrix na Fata (bayanan biopsy, makonni 8 vs. placebo)

  • Procollagen I: +65 %
  • Elastin: +18 %
  • Fibrillin: +6 %, wanda bai kai ga samun ƙididdiga mai mahimmanci ba

Sakamakon fibrillin abu ne da za a iya warewa a kan taken labarai; ba shi da ƙarfi na kimiyya don a kirga shi nasara.

Tsarin Da Aka Bayyana

Taken takardar yana danganta raguwar ƙyallin tabo da “ƙaruwa a samar da matrix na dermal.” Proc­collagen I shi ne farkon collagen nau’in I, babban collagen na gina fata. Elastin na ba fata lankwasa. Hawan matakan duka a rukuni da aka yi magani ya dace da raguwar ƙyallin da aka gani.

Amma, bayanin da ke cikin takardar yana nuna alaka ce da aka auna a cikin gwaji guda. Ba ya nuna cewa canjin matrix ne ya haifar da raguwar tabo. Haka kuma, ba a fayyace yadda peptide ɗin ke aika saƙon zuwa sel‑fata ba. Ka ɗauki wannan tsarin a matsayin mai yuwuwa kuma an tallafa shi da bayanan biopsy, ba a matsayin cikakken bayani ba.

Takaitattun Iyakoki: Karanta Wannan Kafin Ka Saya

Sakamakon suna da ƙarfafa, amma ƙuntatawa suna da mahimmanci kamar su:

  • Mata masu shekaru 45‑65 kawai. Maza da mata ƙasa ko manya ba a gwada su ba.
  • Makonni 8 na shan magani da kuma makonni 4 na bi‑biyan. Ba a san tasiri ko haɗari na amfani na shekara guda ko fiye ba.
  • Peptide ɗaya mai alama. Ba a iya amfani da sakamakon ga sauran kayayyakin collagen ba.
  • Manufa ɗaya kawai: tabon idanu. Ba a ba da rahoto kan sauran wuraren fuska ko jiki ba.
  • Biopsies daga ƙungiyar ƙanana, ba dukan mahalarta 114 ba.
  • Fibrillin bai kai ga samun ma’ana ba.
  • Takardar ba ta ba da rahoton illa; don haka ba za a iya yin ƙirari kan aminci ba.

Masu rubutu sun lura da cewa ƙarancin binciken klinikal da ke tallafawa ikirarin cewa ƙarin abinci na inganta tsufar fata. Wannan gwaji yana ƙara bayanai, amma a matsayin nazari guda kaɗai; maimaita da ƙwararrun masu bincike zai ƙara gamsuwa.

Abinda Yake Nufi Ga Kai: Ka'idojin Amfani

Abin Da Aka Yi Amfani Da Shi

  • Kima: gram 2.5 na peptide collagen mai aiki Verisol
  • Sauƙi: sau ɗaya a rana
  • Tsawon Lokaci: makonni 8 – wannan ne lokacin da aka gwada kuma tasiri ya riga ya bayyana a mako na 4.
  • Lokaci: takardar tana cewa sau ɗaya a rana ne. Ba a gwada safiya ko maraice, ko tare da abinci ko ba tare da abinci ba, don haka babu “lokaci mafi kyau” da aka tabbatar da shi.

Wanda Ya Fi Daɗa

  • Mata tsakanin shekaru 45‑65 da ke son rage layukan ƙarƙasasshe a kusa da idanu, wadda ta yi daidai da ƙungiyar da aka yi gwaji a kai.
  • Mutanen da ke son samfurin da ke da takardun kimiyya, an gwada da placebo.

Wanda Ya Kamata Ya Yi Caution Ko Ya Guje Shi

  • Kowa wanda ba shi cikin rukuni da aka gwada ya kamata ya ɗauki fa’idar a matsayin ba a tabbatar ba.
  • Mutanen da ke da matsalolin abinci ko iyakoki suna buƙatar duba tushen collagen da abubuwan da ke ciki. Takardar ba ta bayyana tushen ba.
  • Matan da ke da ciki, masu shayar da yara, da waɗanda ke da cuta ko ke shan magani su nemi shawarwarin likita. Wannan gwaji ba ya magana kan waɗannan ƙungiyoyi.
  • Idan samfurin da kake amfani da shi ba Verisol ba ne, kada ka ɗauka adadin 20 % ya shafe shi.

Lafiya Takardar ba ta tattauna illa ko ƙarfafa juriya ba, don haka ba za a iya fitar da wani ƙuduri na aminci ba. Kada ka ɗauka wannan a matsayin garanti na rashin illa.

Sa ran gaske Kashi 20 % na raguwar ƙyallin tabo a idanun idan aka kwatanta da placebo abu ne mai auna, amma ba babbar canji ba. Ba zai maye gurbin facelift ba, ko ma maye gurbin kariyar rana. Tasirin ya ci gaba da kasancewa a kalla har makonni 4 bayan an daina, wanda ke nuna ba kawai na ɗan lokaci ba. Babu bayanin yadda zai ɗore fiye da haka.

Kammalawa

Wannan gwaji na ɗaya daga cikin mafi ƙarfi na takardun ɗan adam a bangaren collagen. Gram 2.5 a rana na Verisol na tsawon makonni 8 ya rage ƙyallin tabon idanu da kashi 20 % idan aka kwatanta da placebo, kuma biopsies sun nuna ƙaruwar procollagen I da kashi 65 % da elastin da kashi 18 %. Shaidar ta takaita ne ga mata 45‑65, tsawon lokaci kaɗan, da peptide ɗaya mai alama. Idan kana son maimaitawa, ka nemi wannan takamaiman peptide a wannan kima. In ba haka ba, ka yi la’akari da gwajinka na kanka.

Source: Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113‑119. doi:10.1159/000355523. PubMed

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

A bright, minimalist editorial still life on a pale warm-white stone surface, shot from a slightly elevated three-quarter angle in soft natural window light. At center, a small amber glass supplement bottle with a matte cream label, unbranded, sits beside a few loose white capsules. A pair of weathered hands in a light oatmeal linen sleeve, belonging to an older adult, rests gently near the bottle, with a ceramic mug of tea just out of focus. To the right, a clean glass vial and a delicate glass beaker filled with clear liquid catch the light, hinting at laboratory research without any futuristic touch. A small paper notebook with a handwritten simple line graph rising in a gentle curve lies open nearby, along with a sharpened pencil. Scattered at the edges are soft sprigs of dried eucalyptus and a few pale sage-green leaves, adding an organic note. A faint, abstract molecular diagram printed in muted teal ink on a card leans against the bottle, subtle and graphic. The palette is calm and modern: warm ivory, sage green, soft teal, muted amber, and touches of dusty peach. Long, gentle shadows fall across the surface, and the shallow depth of field blurs the background into creamy neutral tones. The composition leaves generous negative space on the left third for headline text. The overall feel is a trendy health and science journal: clean, airy, trustworthy, and quietly sophisticated, with fine film-like grain and true-to-life color. Ultra-detailed, 16:9 landscape.
supplements

1,000 mg Nicotinamide Riboside a Kullum Yana Kara NAD+ a Kwayoyin Jini Da Kusan 60 % a Manyan Mutane, Binciken Randomized Ya Gano

BY DR. SYNAPSE ·

Binciken da aka wallafa a 2018 a *Nature Communications* ya gwada nicotinamide riboside (NR) a 500 mg sau biyu a rana (jimillar 1,000 mg a rana) tsawon makonni shida a manyan da ke da ƙoshin lafiya. An tabbatar da cewa ba a samu illa ba, sannan amfanin NR ya haɓaka matakin NAD+ a cikin ƙwayoyin garkuwar jini da kusan kashi 60 % idan aka kwatanta da placebo. Masu binciken sun kuma lura da alamu na raguwar hauhawar jini da sassauta jijiyoyin jini, amma ba su da hujja da za su tabbatar da fa’ida, don haka an buƙaci ƙarin gwaje‑gwaje.

A softly lit editorial still life on a pale oat-colored linen surface, shot from a slightly elevated three-quarter angle in a wide landscape frame. At center-left, a small matte white ceramic dish holds a modest pile of fine off-white powder, with a tiny brushed-brass measuring spoon resting beside it. Next to the dish stands a minimalist amber glass supplement bottle with a plain cream label and no readable text. A few capsules spill casually across the linen, some translucent and some opaque ivory.

On the right side of the composition, a ripe blood orange cut in half and a handful of raw almonds sit on a light ash-wood board. A sprig of fresh rosemary adds a muted green accent. A sheer glass of water catches the light and throws a soft, rippled caustic pattern across the fabric.

In the background, out of focus, a woman's hand in a soft sage-green knit sleeve rests near a ceramic mug. This suggests a calm morning routine without showing a face. Behind her, a tall window casts diffused, golden-hour light from the upper left, with gentle shadows and a creamy, shallow depth of field.

The palette is warm and restrained: oat, ivory, terracotta, sage, and amber, with a single pop of coral from the blood orange. A thin, abstract line of muted terracotta paint, like a brushed arc, sweeps across the upper right background. It subtly evokes a rising curve without becoming a literal chart.

The mood is calm, trustworthy, and contemporary, like a premium wellness and science journal feature. The image has crisp focus on the powder and bottle, natural film-like grain, soft contrast, and generous negative space in the upper third for headline overlay. It looks like a high-end editorial photograph with no text, logos, or futuristic elements.
metabolism

Nasara Ta Farko Na NMN a Mutane: 250 mg a Kullum Ya Kara Sensitivity Na Insulin a Tsokar Ƙashi Da Kimanin 25 % a Mata Masu Pre‑diabetes

BY DR. SYNAPSE ·

NMN an dade ana ɗaukar shi a matsayin ‘tauraron ƙasa’ wajen tsawaita rai, amma hujjar ɗan adam ta zo ne ne da sakamakon gwajin Washington University na 2021 da aka wallafa a *Science*. A cikin mata masu post‑menopausal da ke da pre‑diabetes, shan 250 mg na NMN a kowace rana tsawon makonni 10 ya inganta insulin‑sensitivity a tsokar ƙashi da kusan kashi 25 %. Sai dai ba a ga wani tasiri kan matakin sukari a jini ko canjin pre‑diabetes ba.

Approach: The human outcome. Palette: C, Natural.

A close, low-angle shot of a sleeping person's bare forearm and hand resting on a rumpled white cotton duvet, a matte black smart ring on the index finger, with a small electric green LED glint on the ring's inner edge. Early morning daylight comes through a sheer curtain at the left and casts soft golden-green light across the skin, showing fine arm hair and natural skin texture. In the background, out of focus, are a wooden nightstand with a glass of water and the blurred green leaves of a houseplant by the window. The face is not shown. Shot at a 35mm equivalent with shallow depth of field, focused on the ring and knuckles. The mood is calm, restorative and quietly observational, as if the night's data were about to be checked.
supplements

Magnesium L‑Threonate Ya Kara Mafi Kyawun Bacci Mai Zurfi da REM a Kan Oura Bayan Kwanaki 21

BY NOVA CHEN ·

Wani gwaji na bazuwar da aka gudanar a shekarar 2024 ya gwada maganin magnesium da ke ƙara magnesium a kwakwalwa, magnesium L‑threonate (Magtein), a kan manyan mutane 80 da ke da matsalolin barci. Bayan kwanaki 21 da shan gram 1 a rana, rukunin da ya sha MgT ya samu maki mafi girma a bacci mai zurfi da REM a kan abin daidaita barci na Oura fiye da rukunin placebo, tare da ingantaccen yanayi, ƙarfi da faɗakarwa. Koyaya, ƙungiyar placebo ma ta fara tabarbarewa, auna matakan barci ya dogara ne kan na’urar da aka saya don amfani na yau da kullum, ba a asibiti ba, kuma ba a kwatanta threonate da glycinate ko citrate ba. Wannan shi ne ainihin sakamakon, yawan magnesium da gram 1 ke ƙunshe da shi, da ƙalubalen da ke tattare da shi.

Approach: conceptual metaphor. Palette: bold color field.

A single AA-style cylindrical battery, shown as a real object with a bare metal cap and a plain unlabeled matte sleeve, stands upright on a glossy surface. It is photographed from a low three-quarter angle against a saturated tomato-red seamless backdrop. The battery is half-filled with a translucent amber liquid that visibly rises inside a clear glass cutaway section. A thin ribbon of electric green light (#00e676) wraps around its base like a charging band. Soft large-softbox light comes from the upper left and produces crisp highlights on the metal and a clean, slightly blurred red reflection beneath it. A second, shorter battery sits out of focus behind, nearly drained and empty, to suggest contrast. The mood is energetic, optimistic and precise, with a tactile product-photography look and shallow depth of field.
supplements

NR + Pterostilbene na ƙara NAD+ kusan 40–90 % a Gwajin Dan Adam

BY NOVA CHEN ·

Shin kowane kwayar NR da pterostilbene na iya ɗaga matakin NAD+ a manya? A gwajin farko akan mutane (NRPT – Basis), mutane 120 masu shekaru 60‑80 sun sha shi na tsawon mako takwas. Hakan ya haifar da ƙaruwa kusan 40 % a ƙimar da ake bada shawara, kuma kusan 90 % a ƙimar da ta ninka. Wannan ƙaruwa ta ci gaba da kasancewa duk tsawon gwajin, ba tare da wani haɗari mai tsanani ba. Ga abin da lambobin suka nuna, yadda za a fassara ƙimar, da kuma abubuwan da binciken ba zai iya amsa ba.

This page is available in